Laura Mathers tells us about her research assessing surrogate endpoints and their impact on HTA recommendations – ISPOR Posters
Read More
Olivia Dickinson tells us about her research reviewing oncology submissions to NICE to see how often QoL data is accepted.
Michelle James tells us about her experiences and activities in her first few weeks with us, including working on project areas ranging from dermatology to digital healthtech to women’s health. Michelle explains how she has been working with experts from across Mtech Access to bring together different specialities for client projects.
The Mtech Access team reflect on a energising and inspiring ISPOR Europe – with commentary from top 10 influencer Prof Phil Richardson
Congratulations to the winners of our 2022 Values Awards.
With so many patients left waiting for NHS care, what will the long-term impact be? How can Pharma and Medtech support the NHS with systematic challenges, like waiting? Where can...
Read More
Prof Phil Richardson join Mtech Access as Chair and Chief Innovation Officer. His initial focus will be to bring together the NHS, industry and academia to drive innovation through partnership and collaboration.
On 29th September 2022, we brought together market access professionals from across Pharma and Medtech for our NHS Engagement Symposium: ‘People, pathways and payments – Mastering the key pillars of…
In the field of systematic reviews and evidence synthesis, strong, multi-partner teams are critical for moving new drugs from early development and testing in the lab to treating people in…
What do NHS customers value? What drives their decision-making? We asked our pool of NHS Associates – here are their responses.
